PMHNP: Pharmacology Save
Practice questions for this set
Learn 1 /7 Study using Learn
Decreased antipsychotic effects w/ amphetamines
Increased sedation, decreased levels, hypotension w/ barbiturates, BZAs, narcotics
Decreased levels w/ smoking
Decreased effectiveness w/ hypoglycemics
, Selective Serotonin Reuptake Inhibitors
Antipsychotics: Drug Interactions 2
(SSRIs): MOA
Monoamine Oxidase Inhibitors (MAOIs): Serotonin Norepinephrine Reuptake
3 4
Drug Interactions Inhibitors (SNRIs): MOA
Press any key to continue Don't know? Continue
Terms in this set (31)
Decreased antipsychotic effects w/ amphetamines
Increased sedation, decreased levels, hypotension w/ barbiturates,
BZAs, narcotics
Antipsychotics: Drug Interactions
Decreased levels w/ smoking
Decreased effectiveness w/ hypoglycemics
Decreased antiparkinson effects w/ levodopa, increases psychosis
Blocks D2 receptors to decrease DA
Atypical Antipsychotics: MOA Blocks 5HT2 receptors causing reuptake of DA into mesolimbic
pathway
Practice questions for this set
Learn 1 /7 Study using Learn
Decreased antipsychotic effects w/ amphetamines
Increased sedation, decreased levels, hypotension w/ barbiturates, BZAs, narcotics
Decreased levels w/ smoking
Decreased effectiveness w/ hypoglycemics
, Selective Serotonin Reuptake Inhibitors
Antipsychotics: Drug Interactions 2
(SSRIs): MOA
Monoamine Oxidase Inhibitors (MAOIs): Serotonin Norepinephrine Reuptake
3 4
Drug Interactions Inhibitors (SNRIs): MOA
Press any key to continue Don't know? Continue
Terms in this set (31)
Decreased antipsychotic effects w/ amphetamines
Increased sedation, decreased levels, hypotension w/ barbiturates,
BZAs, narcotics
Antipsychotics: Drug Interactions
Decreased levels w/ smoking
Decreased effectiveness w/ hypoglycemics
Decreased antiparkinson effects w/ levodopa, increases psychosis
Blocks D2 receptors to decrease DA
Atypical Antipsychotics: MOA Blocks 5HT2 receptors causing reuptake of DA into mesolimbic
pathway
